Influence of weight variation on long-term mortality of patients with heart failure

被引:0
|
作者
Melo, Nuno [1 ]
Ferreira, Ana I. [1 ]
Silva, Clara [1 ]
Oliveira, Diana [1 ]
Enes, Joao [1 ]
Lume, Maria J. [1 ]
Pereira, Joana [1 ,2 ,3 ]
Araujo, Jose P. [2 ]
Lourenco, Patricia [1 ,2 ]
机构
[1] Ctr Hosp & Univ Sao Joao, Internal Med Dept, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal
[2] Univ Porto, Fac Med, Med Dept, P-4200319 Porto, Portugal
[3] Ctr Hosp & Univ Sao Joao, Heart Failure Clin Internal Med Dept, P-4200319 Porto, Portugal
关键词
Heart failure; Body mass index; Obesity paradox; Weight variation; Prognosis; BODY-MASS INDEX; GASTRIC BYPASS-SURGERY; PROGNOSTIC-FACTOR; OBESITY PARADOX; RISK; IMPACT; ASSOCIATION; CANDESARTAN; REDUCTION; INSIGHTS;
D O I
10.1016/j.acvd.2023.06.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In heart failure, weight loss predicts dismal prognosis. Weight variations have not been addressed in obese patients with heart failure.Aim: To study the impact of weight variation on heart failure mortality according to body mass index strata.Methods: Retrospective study of patients with chronic heart failure with left ventricular ejection fraction < 50%. Only patients with >= 1 year of follow-up were included. Patients with missing data for body mass index at the index and 1-year appointments were excluded. Patients were classified into three groups according to weight variation: weight gain > 5%; weight loss > 5%; and weight stability. Follow-up was set from the 1-year appointment. Cox-regression analysis was used to assess the prognostic impact of weight variation.Results: We studied 589 patients: 69.8% male; mean age, 69 years. Over 1 year, 148 patients (25.1%) gained > 5% weight, 97 (16.5%) lost > 5% weight and the remaining 344 were weight-stable. During 49 months of median follow-up, 248 patients died. Patients who lost > 5% of their weight presented a higher death risk than the others (hazard ratio 1.61, 95% confidence interval 1.18-2.19). After multivariable adjustment, the hazard ratio for death for low/normal-weight patients who lost > 5% of their weight was 1.81 (95% confidence interval 1.02-3.21; P = 0.04) compared with the others. Among the overweight, those who lost > 5% of their weight had a hazard ratio of 2.34 (95% confidence interval 1.32-4.12). In the initially obese subgroup, weight loss > 5% was not associated with prognosis (hazard ratio 1.08, 95% confidence interval 0.53-2.19).Conclusions: Weight loss predicted mortality in low/normal-weight and overweight patients with heart failure. However, in obese patients, significant weight loss did not predict poorer survival. Weight loss should not be discouraged in obese patients with heart failure.(c) 2023 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:403 / 410
页数:8
相关论文
共 50 条
  • [21] Long-term mortality in patients with congestive heart failure treated with cardiac resynchronization therapy
    Soldatova, Anna
    Kuznetsov, Vadim
    Enina, Tatyana
    Krinochkin, Dmitrii
    Dyachkov, Sergey
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C144 - C144
  • [22] Comorbidities in heart failure patients: the impact on re-hospitalization and long-term mortality
    Agostinho, J.
    Alves, P.
    Rigueira, J.
    Ricardo, I.
    Guimaraes, T.
    Goncalves, I.
    Andre, N.
    Santos, R.
    Veiga, F.
    Pedro, M.
    Pinto, F. J.
    Brito, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 390 - 390
  • [23] EFFECT OF INCIDENT HEART FAILURE ON SHORT- AND LONG-TERM MORTALITY OF COPD PATIENTS
    Axson, E. L.
    Sundaram, V.
    Bloom, C. I.
    Bottle, A.
    Cowie, M. R.
    Quint, J. K.
    THORAX, 2019, 74 : A1 - A2
  • [24] The impact of regulatory T lymphocytes on long-term mortality in patients with chronic heart failure
    Sulzgruber, P.
    Koller, L.
    Richter, B.
    Blum, S.
    Huelsmann, M.
    Goliasch, G.
    Wojta, J.
    Niessner, A.
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S267 - S267
  • [25] Predicting Long-Term Mortality in Patients With Acute Heart Failure by Using Machine Learning
    Park, Jiesuck
    Hwang, In-Chang
    Yoon, Yeonyee E.
    Park, Jun-Bean
    Park, Jae-Hyeong
    Cho, Goo-Yeong
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (07) : 1078 - 1087
  • [26] The impact of regulatory T lymphocytes on long-term mortality in patients with chronic heart failure
    Sulzgruber, P.
    Koller, L.
    Richter, B.
    Blum, S.
    Koprak, M.
    Huelsmann, M.
    Pacher, R.
    Goliasch, G.
    Wojta, J.
    Niessner, A.
    CARDIOVASCULAR RESEARCH, 2016, 111 : S21 - S21
  • [27] A simple parameter for long-term mortality in acute heart failure patients: serum albumin
    Cinar, Tufan
    Hayiroglu, Mert Ilker
    Cicek, Vedat
    Orhan, Ahmet Lutfullah
    ACTA CARDIOLOGICA, 2021, 76 (01) : 106 - 106
  • [28] Effects of Spironolactone on Long-term Mortality and Morbidity in Patients With Heart Failure and Mild or No Symptoms
    Vizzardi, Enrico
    Nodari, Savina
    Caretta, Giorgio
    D'Aloia, Antonio
    Pezzali, Natalia
    Faden, Giacomo
    Lombardi, Carlo
    Raddino, Riccardo
    Metra, Marco
    Dei Cas, Livio
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 347 (04): : 271 - 276
  • [29] β-Blocker use in long-term dialysis patients -: Association with hospitalized heart failure and mortality
    Abbott, KC
    Trespalacios, FC
    Agodoa, LY
    Taylor, A
    Bakris, GL
    ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (22) : 2465 - 2471
  • [30] Long-term mortality of heart failure patients with biventricular implant: Pacemaker versus ICD
    Solimene, F.
    Accogli, M.
    Bertaglia, E.
    La Rocca, V.
    De Simone, A.
    Marrazzo, N.
    Shopova, G.
    Pascotto, P.
    Iuliano, A.
    Ciardiello, C.
    Stabile, G.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2007, 18 : S49 - S49